Epithelial-to-mesenchymal transition in cancer: complexity and opportunities

被引：0
作者：
Yun Zhang
Robert A. Weinberg
机构：
[1] Whitehead Institute for Biomedical Research,
[2] MIT Department of Biology,undefined
[3] Ludwig/MIT Center for Molecular Oncology,undefined
来源：
Frontiers of Medicine | 2018年 / 12卷
关键词：
epithelial-to-mesenchymal transition; cancer; metastasis; cancer stem cell;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The cell-biological program termed the epithelial-to-mesenchymal transition (EMT) plays an important role in both development and cancer progression. Depending on the contextual signals and intracellular gene circuits of a particular cell, this program can drive fully epithelial cells to enter into a series of phenotypic states arrayed along the epithelial-mesenchymal phenotypic axis. These cell states display distinctive cellular characteristics, including stemness, invasiveness, drug-resistance and the ability to form metastases at distant organs, and thereby contribute to cancer metastasis and relapse. Currently we still lack a coherent overview of the molecular and biochemical mechanisms inducing cells to enter various states along the epithelial-mesenchymal phenotypic spectrum. An improved understanding of the dynamic and plastic nature of the EMT program has the potential to yield novel therapies targeting this cellular program that may aid in the management of high-grade malignancies.
引用
收藏
页码：361 / 373
页数：12
相关论文
共 1048 条
[51]  
Yang J(2008)Systemic spread is an early step in breast cancer Cancer Cell 13 58-372
[52]  
Ocaña OH(2012)EMT and dissemination precede pancreatic tumor formation Cell 148 349-247
[53]  
Córcoles R(2013)Selection and adaptation during metastatic cancer progression Nature 501 365-1925
[54]  
Fabra A(2016)Prrx1 isoform switching regulates pancreatic cancer invasion and metastatic colonization Genes Dev 30 233-892
[55]  
Moreno-Bueno G(1996)E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain Oncogene 13 1919-829
[56]  
Acloque H(2012)Intratumor heterogeneity and branched evolution revealed by multiregion sequencing N Engl J Med 366 883-337
[57]  
Vega S(2009)Heterogeneity in cancer: cancer stem cells versus clonal evolution Cell 138 822-94
[58]  
Barrallo-Gimeno A(2013)Tumour heterogeneity and cancer cell plasticity Nature 501 328-345
[59]  
Cano A(2018)Tumour heterogeneity and resistance to cancer therapies Nat Rev Clin Oncol 15 81-118
[60]  
Nieto MA(2013)The causes and consequences of genetic heterogeneity in cancer evolution Nature 501 338-88
12345678910